Sanofi receives approval from FDA to make the allergy ingredient levocetirizine dihydrochloride available OTC for the first time, including a formulation indicated for children age 2 and up.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?